gabexate has been researched along with alprostadil in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamada, J; Yamamura, K; Yotsuyanagi, T | 1 |
| Kubota, M; Nakabou, Y; Ojima, M; Takada, K | 1 |
| Fuchimoto, Y; Hoshino, K; Hotta, R; Kawachi, S; Kitajima, M; Komori, K; Morikawa, Y; Nakao, S; Obara, H; Okamura, J; Shimazu, M; Tanabe, M; Yamada, Y | 1 |
3 other study(ies) available for gabexate and alprostadil
| Article | Year |
|---|---|
High-performance liquid chromatographic assay of antiinflammatory drugs incorporated in gel ointments. Separation and stability testing.
Topics: alpha-Cyclodextrins; Alprostadil; Anti-Inflammatory Agents; Chromatography, High Pressure Liquid; Cyclodextrins; Drug Stability; Flufenamic Acid; Gabexate; Gels; Guanidines; Ointments; Prednisolone | 1985 |
A possible approach to the suppression of side effects induced by PGE1.
Topics: Alprostadil; Animals; Atropine; Capillary Permeability; Gabexate; Guanidines; Guinea Pigs; Histamine; Ileum; Inflammation; Male; Muscle Contraction; Papaverine; Piperidines; Rats | 1995 |
Successful liver transplantation across the ABO incompatibility barrier in 6 cases of biliary atresia.
Topics: ABO Blood-Group System; Adolescent; Adult; Alprostadil; Biliary Atresia; Child; Clinical Protocols; Gabexate; Glucocorticoids; Graft Rejection; Graft Survival; Hematologic Agents; Humans; Immunosuppressive Agents; Infant; Infusions, Intravenous; Liver Transplantation; Plasma Exchange; Portal Vein; Splenectomy; Survival Analysis; Treatment Outcome | 2006 |